
==== Front
Eat Weight Disord
Eat Weight Disord
Eating and Weight Disorders
1124-4909
1590-1262
Springer International Publishing Cham

38714632
1655
10.1007/s40519-024-01655-7
Research
Efficacy of multivitamin support following bariatric surgery in patients with obesity: a prospective observational study
Basolo Alessio 1
Bechi Genzano Susanna 1
Vitti Jacopo 1
Salvetti Guido 1
Gilio Donatella 1
Ceccarini Giovanni 1
Scartabelli Giovanna 1
Lippi Chita 1
Bellini Rosario 2
Mancini Rudi 2
D’Imporzano Simone 2
Moretto Carlo 2
Angeli Valentina 1
Troiani Daniela 1
Fierabracci Paola 1
Jaccheri Roberta 1
Calderone Alba 1
Poma Anello M. 3
Chiovato Luca 4
Saponati Giorgio 5
Santini Ferruccio ferruccio.santini@unipi.it

16
1 https://ror.org/05xrcj819 grid.144189.1 0000 0004 1756 8209 Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, 56124 Pisa, Italy
2 https://ror.org/05xrcj819 grid.144189.1 0000 0004 1756 8209 Bariatric Surgery Unit, University Hospital of Pisa, 56124 Pisa, Italy
3 https://ror.org/03ad39j10 grid.5395.a 0000 0004 1757 3729 Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, 56100, Pisa, Italy
4 https://ror.org/00mc77d93 grid.511455.1 Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, PV Italy
5 ISPharm CRO, 55100 Lucca, Italy
6 https://ror.org/03ad39j10 grid.5395.a 0000 0004 1757 3729 University of Pisa, Pisa, Italy
7 5 2024
7 5 2024
2024
29 1 3430 11 2023
2 4 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Purpose

Bariatric surgery (BS), an effective treatment for severe obesity and its comorbidities, may result in micronutrient and vitamin deficiencies. This monocentric prospective observational study aimed at evaluating the efficacy of a specifically designed vitamin/mineral formula (Bariatrifast, BIOITALIA S.r.l., Italy) for preventing and treating micronutrient deficiencies in patients submitted to BS.

Methods

Twenty patients with severe obesity (mean weight and BMI: 123.5 kg (range 88–174) and 43.3 kg/m2 (range 37–54) respectively) underwent BS (10 vertical sleeve gastrectomy VSG, 10 Roux-en-Y gastric bypass, RYGB). The mean age was 49.9 years (range 27–68). After a presurgical visit (V0), follow-up visits were performed at 1, 3, 6 and 12 months after surgery (V1–V4). Recorded data included weight, height and BMI. A complete blood count, measurement of ferritin, folic acid, vitamin B12, ionized calcium, 25 OH vitamin D, parathyroid hormone (PTH) were obtained. Following BS, patients started the daily oral multivitamin and mineral supplement.

Results

All patients achieved a significant weight loss (mean − 34.7 ± 11.8 kg). No deficiencies of various vitamins/micronutrients were detected during the entire study period. The serum concentrations of vitamin B12, 25-OH Vitamin D and folic acid increased over the follow-up period compared with V0 (mean increase 243 ng/L, 23 µg /L, 8 µg/L, respectively). Compared to RYGB, patients who underwent sleeve gastrectomy showed higher levels of 25-OH vitamin D at V2, V3 and V4 (all p < 0.05), and higher levels of Vitamin B12 and folic acid at V4 (p < 0.05 and p < 0.005, respectively). No adverse events were reported.

Conclusion

Following VSG or RYGB, Bariatrifast administration was associated with normal values of essential micronutrients, and it was well-tolerated without evidence of gastrointestinal side effects.

Clinical Trial Registration ClinicalTrials.gov, identifiers NCT06152965

Supplementary Information

The online version contains supplementary material available at 10.1007/s40519-024-01655-7.

Keywords

Obesity
Bariatric surgery
Micronutrients
Multivitamin support
issue-copyright-statement© Springer Nature Switzerland AG 2024
==== Body
pmcIntroduction

Obesity is a chronic condition characterized by the accumulation of excess adipose tissue, posing a significant public health concern [1, 2]. According to the World Health Organization, approximately 13% of adults worldwide have a body mass index (BMI) that, being equal to or exceeding 30 kg/m2, indicates an obesity condition [3]. The main goal of obesity treatment is weight loss that may be achieved by lifestyle intervention as first approach. Pharmacological treatment and bariatric surgery (BS) may be considered in adjunct to lifestyle intervention if the latter was not sufficient [4]. Pharmacotherapy can assist affected patients to lose weight and reduce health risks associated with obesity [5]. However, BS stands up as the most effective treatment for severe obesity [4]. Thus, BS is increasingly performed in patients with severe obesity, as assessed by BMI ≥ 40 kg/m2 or even lower when associated with specific comorbidities [6, 7]. Vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB) are the most frequently used surgical procedures [8]. Although BS effectively reduces body weight, improves metabolic alterations, and enhances overall health [9], it may also lead to micronutrients deficiency [6, 10, 11]. The mechanisms involved in the development of vitamins and mineral deficiency include mainly decreased caloric intake and possibly diminished nutrient absorption due to reduced gastric pouch size (in RYGB) and rearrangement of the digestive tract leading to pH alterations (in both VSG and RYGB) [12]. According to recent guidelines [11, 13], it is recommended to implement systematic vitamin and micronutrients’ supplementation following different surgical procedures, with the aim to ensure sufficient nutritional intake and decrease the risk of deficiencies [14–16]. Several Food (supplements) for Special Medical Purposes (FSMP) are available to improve the nutritional intervention.

This prospective observational study aimed at evaluating the effectiveness and safety of a specific FSMP (Bariatrifast, BIOITALIA S.r.l., Italy) in maintaining an adequate vitamin and micronutrient intake in patients with obesity who underwent VSG or RYGB.

Materials and methods

This observational, prospective study included 20 consecutive patients with severe obesity who underwent BS (11 males, 9 females, all aged ≥ 18 years, with a BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 with at least one obesity-related comorbidity). In our population, 10 patients had hypertension, 5 type 2 diabetes, 2 non-alcoholic liver disease, 7 gastroesophageal reflux disease, 7 dyslipidemia and 2 obstructive sleep apnea. Ten of them underwent VSG and 10 RYGB. Patients were recruited at the Obesity and Lipodystrophy Center, University Hospital of Pisa from April 2021 to February 2023. Previous BS was an exclusion criterion. The choice of the BS procedure was done by a multidisciplinary team based on medical history and obesity-related comorbidities.

Starting from the third day after surgery, a daily tablet of Bariatrifast (supplied free of charge by BIOITALIA S.r.l., Italy) was administered. Each pill contained 65 mg of iron,  175 μg of 25-OH Vitamin D (equivalent to 7000 IU), and several other micronutrients, including vitamins (A, B1, B2, B3, B5, B6, B8, B9, B12, C, E, K), zinc, copper, and selenium (Table 1). The study protocol included a presurgical visit (V0), and 4 follow-up visits at 1 (V1), 3 (V2), 6 (V3), and 12 (V4) months after BS. The follow-up period between V0 and V4 was 373 ± 6 days (mean ± SD).Table 1 Composition of micronutrients and vitamins in each tablet of Bariatrifast

Composition		
Magnesium (mg)	56.3	
Iron (mg)	65.0	
Zinc (mg)	10.0	
Copper (mg)	1.0	
Selenium (µg)	55.0	
C Vitamin (mg)	120.0	
E Vitamin (mg)	100.0	
Thiamine (mg)	10.0	
Riboflavin (mg)	1.3	
B6 Vitamin (mg)	1.5	
Pantothenic acid (mg)	10.0	
Niacin (mg)	10.0	
A Vitamin (µg)	1200.0	
Folic acid (µg)	400.0	
Biotin (µg)	50.0	
B12 Vitamin (µg)	500.0	
Cholecalciferol (D Vitamin) (µg)	175.0*	
K Vitamin (µg)	150.0	
*Equal to 7.000 I.U

Body weight, blood pressure and heart rate were recorded at each visit. Blood tests were also performed and included a complete blood count, measurement of ferritin, ionized calcium, 25-OH Vitamin D, PTH, vitamin B12, folic acid. Blood was drawn after an overnight fast. A digital electronic scale was used to assess body weight, in light clothing. Standing height, without shoes, was measured (to the nearest 1 cm) using a stadiometer. Body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in meters. Classification of overweight and obesity was performed according to conventional definitions [17]. The adherence to the treatment was evaluated for each patient at the end of the follow-up period and it was expressed as a percentage ratio between the number of tablet taken and those supposed to be taken in relation to the treatment period.

The study was approved by the local Ethical Committee (CEAVNO—Comitato Etico Area Vasta Nord Ovest Regione Toscana) and all patients gave their written informed consent.

Statistical analysis

Data were analyzed according to the intention-to treat procedure. Normally distributed variables were expressed as arithmetic mean ± standard deviation (SD). p values < 0.05 were considered significant. Changes from baseline (pre-surgery) parameters were evaluated using the Student’s paired t test or non-parametric tests, as appropriate. Weight change was calculated in both VSG and RYGB groups, and difference between the 2 groups was assessed by Student’s unpaired t test. Two-way ANOVA for repeated measures was used to explore changes in micronutrients/vitamins serum levels over and according to surgical procedures. Post-hoc pairwise t test with Bonferroni correction was used to highlight differences among the two groups at different time points. Differences in safety, tolerability and adherence between the groups were compared by Chi-squared tests.

Results

The anthropometric characteristics of the study population are reported in Table 2. At the time of the presurgical visit, no differences in age, body weight and BMI were observed between RYGB and VSG. Prior to BS, 25-OH Vitamin D deficiency (< 25 µg/L) and folate deficiency (< 3 µg/L) were observed in thirteen patients (65%) and 2 patients (10%), respectively. No abnormal values were observed in the other parameters. As expected, BS induced significant weight loss in all patients from V0 to V4 (Δ =  − 34.7 ± 11.8 kg, ranging from − 57 to − 13). Patients who underwent the RYGB intervention showed a higher percentage of weight loss (− 31 ± 7%) compared with the VSG group (− 25 ± 8%) (Fig. 1), although not statistically significant.Table 2 Anthropometric measures of the study population

	Whole group
n = 20	RYGB
n = 10	VSG
N = 10	p value	
Age (years)	49.9 (27–68)	46.4 (27–68)	53.4 (42–62)	0.1	
Body weight (kg)	123.5 (88–174)	126.0 (88–146)	120.4 (91–174)	0.5	
BMI (kg/m2)	43.3 (37–54)	41.4 (37–45)	45.1 (36–54)	0.09	
Data are presented as mean (minimum–maximum)

BMI body mass index

Fig. 1 A Change in body weight (mean values at each visit) over 12 months in the VSG and RYGB groups. Time 0 corresponds to body weight before BS (V0). B Percent weight loss trajectory (mean values) in the VSG versus RYGB groups over 12 months

Serum concentrations of vitamin B12, 25-OH Vitamin D and folic acid increased over the follow-up period compared with V0 (mean increase at V4 243 ng/L, 23 mcg/L and 8 µg/L, respectively). Using two-way ANOVA for repeated measures, serum levels of 25-OH vitamin D increased over time (p < 0.001) with a significant effect of surgical procedures (p < 0.001). Post-hoc pairwise t test with Bonferroni correction showed higher levels of 25-OH vitamin D in patients who underwent sleeve gastrectomy at V2, V3 and V4 (all p < 0.05, Fig. 2A). Vitamin B12 increased over time (p < 0.001), and post-hoc pairwise t test with Bonferroni correction showed higher levels of Vitamin B12 in patients who underwent sleeve gastrectomy at V4 (p < 0.05, Fig. 2B). Folic acid increased over time (p < 0.001) with a significant effect of surgical procedures (p < 0.05). Post-hoc pairwise t-test with Bonferroni correction showed higher levels of folic acid in patients who underwent sleeve gastrectomy at V4 (p < 0.005, Fig. 2C). Slightly higher values of PTH at V2 and V3 (p < 0.05) were observed after RYGB.Fig. 2 Changes in 25-OH Vitamin D (A), vitamin B12 (B) and folic acid (C) concentrations from baseline over 12 months in the VSG and RYGB. The asterisks represent the significant difference in vitamin levels between groups at each time point by post-hoc pairwise t test with Bonferroni correction (*p < 0.05)

In 7 patients who achieved serum levels of Vit. B12 > 1.000 ng/L at V2 (1 patient with RYGB) and at V3 (4 with VSG and 2 with RYGB), Bariatrifast was replaced by another formula containing lower amounts of vitamins and micronutrients (Bariatric, BIOITALIA, Italy, Table 3) with consequent decline of Vit. B12 values below 1000 ng/L. In the 7 patients who achieved serum levels of Vitamin B12 > 1.000 ng/L, the reduction in body weight (− 39.3 ± 12.8 kg, ranging from − 54 to − 17) was not significantly different from that observed in the other patients (− 32.3 ± 10.9 kg, ranging from − 57 to − 13).Table 3 Composition of micronutrients and vitamins in each tablet of Bariatric

Composition		
Magnesium (mg)	188	
Iron (mg)	30	
Zinc (mg)	10.0	
Selenium (µg)	55.0	
C Vitamin (mg)	120.0	
E Vitamin (mg)	12.0	
Thiamine (mg)	10.0	
Riboflavin (mg)	2.1	
B6 Vitamin (mg)	2.1	
Pantothenic acid (mg)	9.0	
Niacin (mg)	24.0	
A Vitamin (µg)	800.0	
Folic acid (µg)	400.0	
B12 Vitamin (µg)	33.0	
Cholecalciferol (D Vitamin) (µg)	25.0*	
K Vitamin (µg)	38.0	
*Equal to 1000 I.U

No significant changes in serum levels of blood counts, ferritin, and ionized calcium were observed (Table 4). In all patients, no deficiency nor subnormal level of various blood parameters was observed during FSMP administration. No adverse events were reported. Good adherence to oral supplementation was observed (median ratio between the number of tablets taken and tablets scheduled = 97.6% (range 77–100).Table 4 Micronutrients and vitamin measures over the follow-up period stratified by surgical procedure

	Sleeve gastrectomy	Gastric bypass	
V0	V1	V2	V3	V4	V0	V1	V2	V3	V4	
Erythrocytes (× 103/µL)	4971 (457)	4898 (485)	4923 (432)	4858 (556)	4799 (485)	4905 (404)	4899 (358)	4836 (406)	4716 (469)	4758 (432)	
Hemoglobin (g/dL)	14.4 (1.3)	14.2 (1.4)	14.5 (1.1)	14.5 (1.4)	14.4 (1.3)	14.4 (1.4)	14.4 (1.3)	14.3 (1.3)	14.3 (1.5)	14.4 (1.6)	
Leukocytes (/µL)	8279 (2216)	6119 (1080)	7508 (1170)	7346 (1184)	7427 (1200)	7134 (1313)	7531 (3211)	7641 (1291)	7708 (1116)	7271 (1213)	
Platelets (× 103/µL)	273.5 (59)	257.1 (61)	250.9 (48)	256.4 (46)	234.3 (34)	246.0 (86.9)	257.5 (75.9)	250.9 (63.6)	249.7 (69.7)	259.6 (88.3)	
PTH (ng/L)	27.3 (5.8)	25.5 (3.9)	26.6* (8.1)	27.5* (7.7)	28.1 (6.9)	34.9 (14.7)	37.2 (16.9)	39.6 (12.8)	37.6 (7.4)	36.4 (11.9)	
Folic acid (µg/L)	5.5 (4.1)	15.9 (11.0)	11.8 (4.5)	14.9 (4.3)	16.3* (5.5)	5.6 (3.2)	9.2 (4.5)	11.5 (5.0)	12.9 (4.5)	10.2 (4.3)	
Ionized calcium (mmol/L)	1.23 (0.02)	1.24 (0.05)	1.20 (0.09)	1.21 (0.09)	1.23 (0.05)	1.25 (0.04)	1.23 (0.07)	1.24 (0.03)	1.23 (0.04)	1.23 (0.04)	
25-OH Vitamin D (µg/L)	25.1 (14.3)	46.1 (8.7)	62.6* (8.7)	59.9* (10.8)	53.0* (13.4)	16.4 (8.4)	35.0 (10.3)	37.4 (6.2)	41.8 (14.5)	34.6 (9.0)	
Ferritin (µg/L)	173.0 (197)	273.6 (222.6)	169.4 (115.5)	137.5 (73.5)	149.7 (104.3)	200.8 (106.4)	169.0 (115.9)	157.0 (61.8)	141.0 (62.9)	127.8 (67.1)	
Vitamin B12 (ng/L)	434.9 (186.8)	825.0 (322.8)	812.5 (264.8)	937.4 (281.2)	804.5* (172.6)	434.7 (137.6)	760.9 (327.4)	697.8 (447.2)	819.0 (549.0)	557.4 (158.0)	
Each parameter in the table is expressed as mean (standard deviation)

The asterisks represent the significant difference between groups at each time point by post-hoc pairwise t test with Bonferroni correction (*p < 0.05)

Discussion

The current study demonstrates that a brand name vitamin/mineral formula (Bariatrifast) was associated with normal values of essential micronutrients during a 1-year follow-up period after VSG or RYGB. Good adherence and no side effects were observed.

BS can induce nutritional deficits that may exacerbate preexisting micronutrients deficiencies [18–21], which result from the poor nutritional quality of the diet, e.g. lack of fruits and vegetables (rich sources of vitamins and minerals), and from specific factors unique to patients with obesity [18, 22]. The prevalence of 25-OH vitamin D deficiency was reported to be 35% higher in individuals with obesity compared with normal weight subjects [23, 24]. Iron deficiency and low hemoglobin levels were reported to occur from 0 to 47% in individuals scheduled for BS [21, 25–27]. Folic acid deficiency rates before BS varied from 0 to 23% [18, 20, 27, 28], while vitamin B12 deficiency was reported to range from 0 to 23% [27, 29].

Starting from preexisting nutritional deficits, BS can make the situation worse. Iron deficiency is highly prevalent after VSG and RYGB, affecting approximately 33% of patients [30, 31], mainly in menstruating women [11]. This condition may be due to the reduced intake of iron-rich foods in the initial months after BS [32]. Current recommendations advise a daily intake of 18 mg of iron in men and non-anemic patients, and of 45–60 mg in menstruating women [11, 33]. Our results show that, by supplementing 65 mg of iron per day, the serum levels of iron were adequate during the whole follow-up period.

Vitamin B12 deficiency is a well-known complication of BS, and it is mainly due to reduced intake [11, 33]. Vitamin B12 undergoes degradation in the gastric acid environment. Consequently, cells in the stomach release intrinsic factor, which binds to vitamin B12. This process takes place in the duodenum, with actual absorption occurring in the ileum [34]. When the intestinal tract is either bypassed or altered (e.g. after gastric bypass or duodenal switch), a reduction in vitamin B12 absorption may occur [35]. Some studies reveal that after RYGB, vitamin B12 deficiency is more prevalent than after VSG [36, 37]. Recommended vitamin B12 supplementation varies based on the administration method: either a daily oral intake of 350–1000 μg or a monthly intramuscular injection of 1000 μg is advised, regardless of the surgery type [33, 35]. The results of the present study indicate that the oral administration of 500 μg of vitamin B12 produces an increase in serum vitamin B12 concentrations that, throughout the study, were found to be in the normal range in the majority of investigated patients. As stated by the NIH office for dietary supplements, the Food and Nutrition Board of the Institute of Medicine does not establish a upper intake level for Vitamin B12 [38], due to its low potential toxicity even at large doses. Vitamin B12 is generally considered to be safe because the body does not store excess amounts. Despite none of the 7 patients who achieved serum levels of Vitamin B12 > 1.000 ng/L complained of any side effect, we decided to replace Bariatrifast with an oral formula containing a lower amount of this vitamin.

Folic acid deficiency is also observed after BS due to inadequate intake [11, 36, 39]. Generally, patients are recommended a daily 400–800 μg dose, while reproductive-age women might require 800–1000 μg daily [11]. We observed that the administration of 400 µg prevented folic acid deficiency, while leading to a progressive increase in its levels, though remaining within the normal range over the follow-up period.

Anemia frequently occurs after BS. A recent meta-analysis demonstrated a similar prevalence of anemia in obese patients submitted to either RYGB or VSG [36]. In our study population, hematological parameters, including hemoglobin levels, remained within the normal range throughout the treatment/observation period, and no case of anemia was recorded. This successful outcome can be attributed to the normalization of iron, vitamin B12 and folic acid.

Independently of the type of BS [40], 25-OH Vitamin D deficiency occurs in 25–73% of operated patients, and it may lead to decreased bone mineral density and worsened bone turnover [41, 42]. Some studies show a consistent increase in fracture risk after RYGB compared with other procedures [43–45], but randomized controlled trials do not report a higher risk of fractures in BS-treated patients compared with controls [46–48]. In patients with obesity who followed a dietary intervention promoting important weight loss, an increase in 25-OH vitamin D has been reported [49]. Since Vitamin D is stored in adipose tissue, its elevation may be due to increased release consequent to loss in fat mass.

Current guidelines recommend administering at least a 2000 IU daily supplementation and periodically monitoring 25-OH Vitamin D levels [24]. In our study, the administration of 175 µg (7000 UI/day) of 25-OH Vitamin D increased the serum level of this vitamin, which were found to be ≥ 25 µg/L in all subjects, even in those starting with a presurgical level < 20 ng/ml. Low 25-OH Vitamin D levels can reduce intestinal calcium absorption. Consequently, the parathyroid glands may increase the production of PTH to balance serum calcium levels, potentially resulting in secondary hyperparathyroidism. Our results showed normal and stable serum values of PTH and ionized calcium throughout the course of the study.

Vitamin B1 (thiamine) deficiency can occur after BS due to inadequate intake or persistent vomiting [11, 50]. After BS, the prevalence of thiamine deficiency is estimated at 18% of operated patients [51]. Vitamin B1 deficiency can have consequences on the cardiovascular, nervous, and immune systems, resulting in conditions such as wet beriberi, dry beriberi, or Wernicke–Korsakoff syndrome [50, 52]. The recommended daily intake of thiamin is 1.2 mg per day in men and 1.1 mg per day in women [13, 53]. However, the American Society for Parenteral and Enteral Nutrition suggests a thiamine intake ranging from 1.2 mg to a maximum of 10 mg per day [13, 30, 54]. In our study cohort, we did not observe any clinical sign of vitamin B1 deficiency by administering 10 mg/day of this vitamin.

The post-surgical management of patients is critical because of the BS-induced decrease of nutrients intake and/or absorption [55, 56]. To prevent micronutrient deficiencies, the early administration of targeted food supplements after BS is crucial [21]. However, ensuring patients’ compliance with multiple supplements can be challenging and it may lead to a high incidence of unsuccessful outcomes, which may increase the sanitation costs due to a rise in emergency admissions, hospitalizations, and treatment expenses [57]. Simplifying the regimen into a single product may enhance adherence and minimize the risk of nutritional deficits [58].

Our study has some limitations. After BS, there is a potential risk to develop deficiencies of additional vitamins (A, K, E, B6) and micronutrients (copper, zinc, magnesium) [11, 20, 33]. The recommended doses of these micronutrients are included in Bariatrifast, although no specific measures were obtained to verify their efficacy. The relatively small sample size, lack of a control group undergoing specific dietary regimen, reliance on self-reported compliance with supplement regimens and the short follow-up period might limit the study's ability to draw complete conclusions.

Conclusion

In the current study, the administration of an FSMP (Bariatrifast) was associated with normal values of vitamins and minerals in patients with obesity who underwent BS. A satisfactory adherence to Bariatrifast treatment and its safety were recorded.

Supplementary Information

Below is the link to the electronic supplementary material.Supplementary file1 (DOCX 31 KB)

Acknowledgements

None.

Author contributions

A.B. interpreted data and wrote the manuscript. F.S., G.S., S.B.G., J.V., G.Sa, D.G., G.C., G.Sc., C.L., P.F.,, A.C., L.C., assisted with the interpretation of the data and revised the manuscript. F.S. designed the study protocol. J.V., R.J., D.T and V.A. performed nutritional counseling during follow-up visits. A.M.P performed the statistical analysis. C.M., R.B. S.D. and R.M. performed surgical procedures. All authors read, critically revised the draft and approved the final manuscript. A.B. and F.S. have full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Funding

The study was sponsored by BIOITALIA S.r.l., Italy.

Data availability

Some or all datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.

Declarations

Ethics approval

The study has been approved by the local Ethical Committee (Comitato Etico Area Vasta Nord-Ovest). The procedures employed in the study are in accordance with the ethical standards of the Local Ethical Committee and with the 1964 Helsinki Declaration and its later amendments.

Conflict of interests

J.V., R.J., V.A., C.L. have received reimbursement for attending symposia from BIOITALIA S.r.l. The other authors declare no conflict of interest. The sponsor had no role in the collection, analyses, or interpretation of data, and in writing the manuscript.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Janssen F Bardoutsos A Vidra N Obesity prevalence in the long-term future in 18 European countries and in the USA Obes Facts 2020 13 5 514 527 10.1159/000511023 33075798
Janssen F, Bardoutsos A, Vidra N (2020) Obesity prevalence in the long-term future in 18 European countries and in the USA. Obes Facts 13(5):514–52733075798 10.1159/000511023
2. Blüher M Obesity: global epidemiology and pathogenesis Nat Rev Endocrinol 2019 15 5 288 298 10.1038/s41574-019-0176-8 30814686
Blüher M (2019) Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 15(5):288–29830814686 10.1038/s41574-019-0176-8
3. World Health Organization. Obesity and overweight fact sheet; 2016. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 18 Sept 2021.
4. Yumuk V Tsigos C Fried M Schindler K Busetto L Micic D Toplak H European guidelines for obesity management in adults Obes Facts 2015 8 6 402 424 10.1159/000442721 26641646
Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H (2015) European guidelines for obesity management in adults. Obes Facts 8(6):402–42426641646 10.1159/000442721
5. Toplak H Woodward E Yumuk V Oppert JM Halford JC Frühbeck G 2014 EASO position statement on the use of anti-obesity drugs Obes Facts 2015 8 3 166 174 10.1159/000430801 25968960
Toplak H, Woodward E, Yumuk V, Oppert JM, Halford JC, Frühbeck G (2015) 2014 EASO position statement on the use of anti-obesity drugs. Obes Facts 8(3):166–17425968960 10.1159/000430801
6. Di Lorenzo N Antoniou SA Batterham RL Busetto L Godoroja D Iossa A Carrano FM Agresta F Alarçon I Azran C Bouvy N Balaguè Ponz C Buza M Copaescu C De Luca M Dicker D Di Vincenzo A Felsenreich DM Francis NK Fried M Gonzalo Prats B Goitein D Halford JCG Herlesova J Kalogridaki M Ket H Morales-Conde S Piatto G Prager G Pruijssers S Pucci A Rayman S Romano E Sanchez-Cordero S Vilallonga R Silecchia G Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC EASO and ESPCOP Surg Endosc 2020 34 6 2332 2358 10.1007/s00464-020-07555-y 32328827
Di Lorenzo N, Antoniou SA, Batterham RL, Busetto L, Godoroja D, Iossa A, Carrano FM, Agresta F, Alarçon I, Azran C, Bouvy N, Balaguè Ponz C, Buza M, Copaescu C, De Luca M, Dicker D, Di Vincenzo A, Felsenreich DM, Francis NK, Fried M, Gonzalo Prats B, Goitein D, Halford JCG, Herlesova J, Kalogridaki M, Ket H, Morales-Conde S, Piatto G, Prager G, Pruijssers S, Pucci A, Rayman S, Romano E, Sanchez-Cordero S, Vilallonga R, Silecchia G (2020) Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC. EASO and ESPCOP Surg Endosc 34(6):2332–235832328827 10.1007/s00464-020-07555-y
7. Gildea A Shukla S Parretti H Khan O Referral criteria and assessment for bariatric surgery: summary of updated NICE guidance BMJ 2023 382 1880 10.1136/bmj.p1880 37643791
Gildea A, Shukla S, Parretti H, Khan O (2023) Referral criteria and assessment for bariatric surgery: summary of updated NICE guidance. BMJ 382:188037643791 10.1136/bmj.p1880
8. Angrisani L Santonicola A Iovino P Vitiello A Zundel N Buchwald H Scopinaro N Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014 Obes Surg 2017 27 9 2279 2289 10.1007/s11695-017-2666-x 28405878
Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, Scopinaro N (2017) Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg 27(9):2279–228928405878 10.1007/s11695-017-2666-x
9. Adams TD Davidson LE Litwin SE Kim J Kolotkin RL Nanjee MN Gutierrez JM Frogley SJ Ibele AR Brinton EA Hopkins PN McKinlay R Simper SC Hunt SC Weight and metabolic outcomes 12 years after gastric bypass N Engl J Med 2017 377 12 1143 1155 10.1056/NEJMoa1700459 28930514
Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, Hopkins PN, McKinlay R, Simper SC, Hunt SC (2017) Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med 377(12):1143–115528930514 10.1056/NEJMoa1700459
10. Patel JJ Mundi MS Hurt RT Wolfe B Martindale RG Micronutrient deficiencies after bariatric surgery: an emphasis on vitamins and trace minerals [formula: see text] Nutr Clin Pract 2017 32 4 471 480 10.1177/0884533617712226 28609642
Patel JJ, Mundi MS, Hurt RT, Wolfe B, Martindale RG (2017) Micronutrient deficiencies after bariatric surgery: an emphasis on vitamins and trace minerals [formula: see text]. Nutr Clin Pract 32(4):471–48028609642 10.1177/0884533617712226
11. Busetto L Dicker D Azran C Batterham RL Farpour-Lambert N Fried M Hjelmesæth J Kinzl J Leitner DR Makaronidis JM Schindler K Toplak H Yumuk V Practical recommendations of the obesity management task force of the European Association for the study of obesity for the post-bariatric surgery medical management Obes Facts 2017 10 6 597 632 10.1159/000481825 29207379
Busetto L, Dicker D, Azran C, Batterham RL, Farpour-Lambert N, Fried M, Hjelmesæth J, Kinzl J, Leitner DR, Makaronidis JM, Schindler K, Toplak H, Yumuk V (2017) Practical recommendations of the obesity management task force of the European Association for the study of obesity for the post-bariatric surgery medical management. Obes Facts 10(6):597–63229207379 10.1159/000481825
12. Barazzoni R Gortan CG Double burden of malnutrition in persons with obesity Rev Endocr Metab Disord 2020 21 3 307 313 10.1007/s11154-020-09578-1 32766943
Barazzoni R, Gortan CG (2020) Double burden of malnutrition in persons with obesity. Rev Endocr Metab Disord 21(3):307–31332766943 10.1007/s11154-020-09578-1
13. Tabesh MR Maleklou F Ejtehadi F Alizadeh Z Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: a practical guideline Obes Surg 2019 29 10 3385 3400 10.1007/s11695-019-04112-y 31367987
Tabesh MR, Maleklou F, Ejtehadi F, Alizadeh Z (2019) Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: a practical guideline. Obes Surg 29(10):3385–340031367987 10.1007/s11695-019-04112-y
14. Coupaye M Rivière P Breuil MC Castel B Bogard C Dupré T Flamant M Msika S Ledoux S Comparison of nutritional status during the first year after sleeve gastrectomy and Roux-en-Y gastric bypass Obes Surg 2014 24 2 276 283 10.1007/s11695-013-1089-6 24122661
Coupaye M, Rivière P, Breuil MC, Castel B, Bogard C, Dupré T, Flamant M, Msika S, Ledoux S (2014) Comparison of nutritional status during the first year after sleeve gastrectomy and Roux-en-Y gastric bypass. Obes Surg 24(2):276–28324122661 10.1007/s11695-013-1089-6
15. Verger EO Aron-Wisnewsky J Dao MC Kayser BD Oppert JM Bouillot JL Torcivia A Clément K Micronutrient and protein deficiencies after gastric bypass and sleeve gastrectomy: a 1-year follow-up Obes Surg 2016 26 4 785 796 10.1007/s11695-015-1803-7 26205215
Verger EO, Aron-Wisnewsky J, Dao MC, Kayser BD, Oppert JM, Bouillot JL, Torcivia A, Clément K (2016) Micronutrient and protein deficiencies after gastric bypass and sleeve gastrectomy: a 1-year follow-up. Obes Surg 26(4):785–79626205215 10.1007/s11695-015-1803-7
16. Aron-Wisnewsky J Verger EO Bounaix C Dao MC Oppert JM Bouillot JL Chevallier JM Clément K Nutritional and protein deficiencies in the short term following both gastric bypass and gastric banding PLoS ONE 2016 11 2 e0149588 10.1371/journal.pone.0149588 26891123
Aron-Wisnewsky J, Verger EO, Bounaix C, Dao MC, Oppert JM, Bouillot JL, Chevallier JM, Clément K (2016) Nutritional and protein deficiencies in the short term following both gastric bypass and gastric banding. PLoS ONE 11(2):e014958826891123 10.1371/journal.pone.0149588
17. Bray GA Heisel WE Afshin A Jensen MD Dietz WH Long M Kushner RF Daniels SR Wadden TA Tsai AG Hu FB Jakicic JM Ryan DH Wolfe BM Inge TH The science of obesity management: an endocrine society scientific statement Endocr Rev 2018 39 2 79 132 10.1210/er.2017-00253 29518206
Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, Kushner RF, Daniels SR, Wadden TA, Tsai AG, Hu FB, Jakicic JM, Ryan DH, Wolfe BM, Inge TH (2018) The science of obesity management: an endocrine society scientific statement. Endocr Rev 39(2):79–13229518206 10.1210/er.2017-00253
18. Krzizek EC Brix JM Herz CT Kopp HP Schernthaner GH Schernthaner G Ludvik B Prevalence of micronutrient deficiency in patients with morbid obesity before bariatric surgery Obes Surg 2018 28 3 643 648 10.1007/s11695-017-2902-4 28849358
Krzizek EC, Brix JM, Herz CT, Kopp HP, Schernthaner GH, Schernthaner G, Ludvik B (2018) Prevalence of micronutrient deficiency in patients with morbid obesity before bariatric surgery. Obes Surg 28(3):643–64828849358 10.1007/s11695-017-2902-4
19. Kobylińska M Antosik K Decyk A Kurowska K Malnutrition in obesity: is it possible? Obes Facts 2022 15 1 19 25 10.1159/000519503 34749356
Kobylińska M, Antosik K, Decyk A, Kurowska K (2022) Malnutrition in obesity: is it possible? Obes Facts 15(1):19–2534749356 10.1159/000519503
20. O'Kane M Parretti HM Pinkney J Welbourn R Hughes CA Mok J Walker N Thomas D Devin J Coulman KD Pinnock G Batterham RL Mahawar KK Sharma M Blakemore AI McMillan I Barth JH British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update Obes Rev 2020 21 11 e13087 10.1111/obr.13087 32743907
O’Kane M, Parretti HM, Pinkney J, Welbourn R, Hughes CA, Mok J, Walker N, Thomas D, Devin J, Coulman KD, Pinnock G, Batterham RL, Mahawar KK, Sharma M, Blakemore AI, McMillan I, Barth JH (2020) British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev 21(11):e1308732743907 10.1111/obr.13087
21. Aguas-Ayesa M Yárnoz-Esquíroz P Olazarán L Gómez-Ambrosi J Frühbeck G Precision nutrition in the context of bariatric surgery Rev Endocr Metab Disord 2023 10.1007/s11154-023-09794-5:1-13 36928810
Aguas-Ayesa M, Yárnoz-Esquíroz P, Olazarán L, Gómez-Ambrosi J, Frühbeck G (2023) Precision nutrition in the context of bariatric surgery. Rev Endocr Metab Disord. 10.1007/s11154-023-09794-5:1-1336928810 10.1007/s11154-023-09794-5:1-13
22. Argyrakopoulou G Konstantinidou SK Dalamaga M Kokkinos A Nutritional deficiencies before and after bariatric surgery: prevention and treatment Curr Nutr Rep 2022 11 2 95 101 10.1007/s13668-022-00400-9 35174473
Argyrakopoulou G, Konstantinidou SK, Dalamaga M, Kokkinos A (2022) Nutritional deficiencies before and after bariatric surgery: prevention and treatment. Curr Nutr Rep 11(2):95–10135174473 10.1007/s13668-022-00400-9
23. Pereira-Santos M Costa PR Assis AM Santos CA Santos DB Obesity and vitamin D deficiency: a systematic review and meta-analysis Obes Rev 2015 16 4 341 349 10.1111/obr.12239 25688659
Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB (2015) Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16(4):341–34925688659 10.1111/obr.12239
24. Giustina A di Filippo L Facciorusso A Adler RA Binkley N Bollerslev J Bouillon R Casanueva FF Cavestro GM Chakhtoura M Conte C Donini LM Ebeling PR Fassio A Frara S Gagnon C Latella G Marcocci C Mechanick JI Minisola S Rizzoli R Santini F Shaker JL Sempos C Ulivieri FM Virtanen JK Napoli N Schafer AL Bilezikian JP Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis Rev Endocr Metab Disord 2023 10.1007/s11154-023-09831-3 37665480
Giustina A, di Filippo L, Facciorusso A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Casanueva FF, Cavestro GM, Chakhtoura M, Conte C, Donini LM, Ebeling PR, Fassio A, Frara S, Gagnon C, Latella G, Marcocci C, Mechanick JI, Minisola S, Rizzoli R, Santini F, Shaker JL, Sempos C, Ulivieri FM, Virtanen JK, Napoli N, Schafer AL, Bilezikian JP (2023) Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis. Rev Endocr Metab Disord. 10.1007/s11154-023-09831-337665480 10.1007/s11154-023-09831-3
25. Inge TH Courcoulas AP Jenkins TM Michalsky MP Helmrath MA Brandt ML Harmon CM Zeller MH Chen MK Xanthakos SA Horlick M Buncher CR Weight loss and health status 3 years after bariatric surgery in adolescents N Engl J Med 2016 374 2 113 123 10.1056/NEJMoa1506699 26544725
Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Helmrath MA, Brandt ML, Harmon CM, Zeller MH, Chen MK, Xanthakos SA, Horlick M, Buncher CR (2016) Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med 374(2):113–12326544725 10.1056/NEJMoa1506699
26. Al-Mutawa A Al-Sabah S Anderson AK Al-Mutawa M Evaluation of nutritional status post laparoscopic sleeve gastrectomy-5-year outcomes Obes Surg 2018 28 6 1473 1483 10.1007/s11695-017-3041-7 29197046
Al-Mutawa A, Al-Sabah S, Anderson AK, Al-Mutawa M (2018) Evaluation of nutritional status post laparoscopic sleeve gastrectomy-5-year outcomes. Obes Surg 28(6):1473–148329197046 10.1007/s11695-017-3041-7
27. Peterson LA Cheskin LJ Furtado M Papas K Schweitzer MA Magnuson TH Steele KE Malnutrition in bariatric surgery candidates: multiple micronutrient deficiencies prior to surgery Obes Surg 2016 26 4 833 838 10.1007/s11695-015-1844-y 26297429
Peterson LA, Cheskin LJ, Furtado M, Papas K, Schweitzer MA, Magnuson TH, Steele KE (2016) Malnutrition in bariatric surgery candidates: multiple micronutrient deficiencies prior to surgery. Obes Surg 26(4):833–83826297429 10.1007/s11695-015-1844-y
28. van Rutte PW Aarts EO Smulders JF Nienhuijs SW Nutrient deficiencies before and after sleeve gastrectomy Obes Surg 2014 24 10 1639 1646 10.1007/s11695-014-1225-y 24706197
van Rutte PW, Aarts EO, Smulders JF, Nienhuijs SW (2014) Nutrient deficiencies before and after sleeve gastrectomy. Obes Surg 24(10):1639–164624706197 10.1007/s11695-014-1225-y
29. Aasheim ET Hofsø D Hjelmesaeth J Birkeland KI Bøhmer T Vitamin status in morbidly obese patients: a cross-sectional study Am J Clin Nutr 2008 87 2 362 369 10.1093/ajcn/87.2.362 18258626
Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T (2008) Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 87(2):362–36918258626 10.1093/ajcn/87.2.362
30. Parrott J Frank L Rabena R Craggs-Dino L Isom KA Greiman L American society for metabolic and bariatric surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients Surg Obes Relat Dis 2017 13 5 727 741 10.1016/j.soard.2016.12.018 28392254
Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L (2017) American society for metabolic and bariatric surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis 13(5):727–74128392254 10.1016/j.soard.2016.12.018
31. Sandvik J Bjerkan KK Græslie H Hoff DAL Johnsen G Klöckner C Mårvik R Nymo S Hyldmo ÅA Kulseng BE Iron deficiency and anemia 10 years after Roux-en-Y gastric bypass for severe obesity Front Endocrinol (Lausanne) 2021 12 679066 10.3389/fendo.2021.679066 34630319
Sandvik J, Bjerkan KK, Græslie H, Hoff DAL, Johnsen G, Klöckner C, Mårvik R, Nymo S, Hyldmo ÅA, Kulseng BE (2021) Iron deficiency and anemia 10 years after Roux-en-Y gastric bypass for severe obesity. Front Endocrinol (Lausanne) 12:67906634630319 10.3389/fendo.2021.679066
32. Bjørklund G Peana M Pivina L Dosa A Aaseth J Semenova Y Chirumbolo S Medici S Dadar M Costea DO Iron deficiency in obesity and after bariatric surgery Biomolecules 2021 11 5 613 10.3390/biom11050613 33918997
Bjørklund G, Peana M, Pivina L, Dosa A, Aaseth J, Semenova Y, Chirumbolo S, Medici S, Dadar M, Costea DO (2021) Iron deficiency in obesity and after bariatric surgery. Biomolecules 11(5):61333918997 10.3390/biom11050613
33. Mechanick JI Apovian C Brethauer S Garvey WT Joffe AM Kim J Kushner RF Lindquist R Pessah-Pollack R Seger J Urman RD Adams S Cleek JB Correa R Figaro MK Flanders K Grams J Hurley DL Kothari S Seger MV Still CD Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists Surg Obes Relat Dis 2020 16 2 175 247 10.1016/j.soard.2019.10.025 31917200
Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD (2020) Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis 16(2):175–24731917200 10.1016/j.soard.2019.10.025
34. Guéant JL Guéant-Rodriguez RM Alpers DH Vitamin B12 absorption and malabsorption Vitam Horm 2022 119 241 274 10.1016/bs.vh.2022.01.016 35337622
Guéant JL, Guéant-Rodriguez RM, Alpers DH (2022) Vitamin B12 absorption and malabsorption. Vitam Horm 119:241–27435337622 10.1016/bs.vh.2022.01.016
35. Al Mansoori A Shakoor H Ali HI Feehan J Al Dhaheri AS Cheikh Ismail L Bosevski M Apostolopoulos V Stojanovska L The effects of bariatric surgery on vitamin b status and mental health Nutrients 2021 13 4 1383 10.3390/nu13041383 33923999
Al Mansoori A, Shakoor H, Ali HI, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Bosevski M, Apostolopoulos V, Stojanovska L (2021) The effects of bariatric surgery on vitamin b status and mental health. Nutrients 13(4):138333923999 10.3390/nu13041383
36. Kwon Y Ha J Lee YH Kim D Lee CM Kim JH Park S Comparative risk of anemia and related micronutrient deficiencies after Roux-en-Y gastric bypass and sleeve gastrectomy in patients with obesity: an updated meta-analysis of randomized controlled trials Obes Rev 2022 23 4 e13419 10.1111/obr.13419 35048495
Kwon Y, Ha J, Lee YH, Kim D, Lee CM, Kim JH, Park S (2022) Comparative risk of anemia and related micronutrient deficiencies after Roux-en-Y gastric bypass and sleeve gastrectomy in patients with obesity: an updated meta-analysis of randomized controlled trials. Obes Rev 23(4):e1341935048495 10.1111/obr.13419
37. Antoniewicz A Kalinowski P Kotulecka KJ Kocoń P Paluszkiewicz R Remiszewski P Zieniewicz K Nutritional deficiencies in patients after Roux-en-Y gastric bypass and sleeve gastrectomy during 12-month follow-up Obes Surg 2019 29 10 3277 3284 10.1007/s11695-019-03985-3 31201694
Antoniewicz A, Kalinowski P, Kotulecka KJ, Kocoń P, Paluszkiewicz R, Remiszewski P, Zieniewicz K (2019) Nutritional deficiencies in patients after Roux-en-Y gastric bypass and sleeve gastrectomy during 12-month follow-up. Obes Surg 29(10):3277–328431201694 10.1007/s11695-019-03985-3
38. Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference I, its Panel on Folate OBV, Choline. The National Academies Collection: Reports funded by National Institutes of Health. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B(6), Folate, Vitamin B(12), Pantothenic Acid, Biotin, and Choline, 10.17226/6015. Washington (DC): National Academies Press (US) Copyright © 1998, National Academy of Sciences; 1998.
39. Khan KM, Jialal I. Folic acid deficiency. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright©2023, StatPearls Publishing LLC; 2023.
40. Lupoli R Lembo E Saldalamacchia G Avola CK Angrisani L Capaldo B Bariatric surgery and long-term nutritional issues World J Diabetes 2017 8 11 464 474 10.4239/wjd.v8.i11.464 29204255
Lupoli R, Lembo E, Saldalamacchia G, Avola CK, Angrisani L, Capaldo B (2017) Bariatric surgery and long-term nutritional issues. World J Diabetes 8(11):464–47429204255 10.4239/wjd.v8.i11.464
41. Paccou J Caiazzo R Lespessailles E Cortet B Bariatric surgery and osteoporosis Calcif Tissue Int 2022 110 5 576 591 10.1007/s00223-020-00798-w 33403429
Paccou J, Caiazzo R, Lespessailles E, Cortet B (2022) Bariatric surgery and osteoporosis. Calcif Tissue Int 110(5):576–59133403429 10.1007/s00223-020-00798-w
42. Schafer AL Vitamin D and intestinal calcium transport after bariatric surgery J Steroid Biochem Mol Biol 2017 173 202 210 10.1016/j.jsbmb.2016.12.012 28027914
Schafer AL (2017) Vitamin D and intestinal calcium transport after bariatric surgery. J Steroid Biochem Mol Biol 173:202–21028027914 10.1016/j.jsbmb.2016.12.012
43. Yu EW Kim SC Sturgeon DJ Lindeman KG Weissman JS Fracture risk after Roux-en-Y gastric bypass vs adjustable gastric banding among medicare beneficiaries JAMA Surg 2019 154 8 746 753 10.1001/jamasurg.2019.1157 31090893
Yu EW, Kim SC, Sturgeon DJ, Lindeman KG, Weissman JS (2019) Fracture risk after Roux-en-Y gastric bypass vs adjustable gastric banding among medicare beneficiaries. JAMA Surg 154(8):746–75331090893 10.1001/jamasurg.2019.1157
44. Ahlin S Peltonen M Sjöholm K Anveden Å Jacobson P Andersson-Assarsson JC Taube M Larsson I Lohmander LS Näslund I Svensson PA Carlsson LMS Fracture risk after three bariatric surgery procedures in Swedish obese subjects: up to 26 years follow-up of a controlled intervention study J Intern Med 2020 287 5 546 557 10.1111/joim.13020 32128923
Ahlin S, Peltonen M, Sjöholm K, Anveden Å, Jacobson P, Andersson-Assarsson JC, Taube M, Larsson I, Lohmander LS, Näslund I, Svensson PA, Carlsson LMS (2020) Fracture risk after three bariatric surgery procedures in Swedish obese subjects: up to 26 years follow-up of a controlled intervention study. J Intern Med 287(5):546–55732128923 10.1111/joim.13020
45. Ablett AD Boyle BR Avenell A Fractures in adults after weight loss from bariatric surgery and weight management programs for obesity: systematic review and meta-analysis Obes Surg 2019 29 4 1327 1342 10.1007/s11695-018-03685-4 30725431
Ablett AD, Boyle BR, Avenell A (2019) Fractures in adults after weight loss from bariatric surgery and weight management programs for obesity: systematic review and meta-analysis. Obes Surg 29(4):1327–134230725431 10.1007/s11695-018-03685-4
46. Maghrabi AH Wolski K Abood B Licata A Pothier C Bhatt DL Nissen S Brethauer SA Kirwan JP Schauer PR Kashyap SR Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy Obesity (Silver Spring) 2015 23 12 2344 2348 10.1002/oby.21150 26193177
Maghrabi AH, Wolski K, Abood B, Licata A, Pothier C, Bhatt DL, Nissen S, Brethauer SA, Kirwan JP, Schauer PR, Kashyap SR (2015) Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy. Obesity (Silver Spring) 23(12):2344–234826193177 10.1002/oby.21150
47. Hofsø D Nordstrand N Johnson LK Karlsen TI Hager H Jenssen T Bollerslev J Godang K Sandbu R Røislien J Hjelmesaeth J Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention Eur J Endocrinol 2010 163 5 735 745 10.1530/EJE-10-0514 20798226
Hofsø D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollerslev J, Godang K, Sandbu R, Røislien J, Hjelmesaeth J (2010) Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 163(5):735–74520798226 10.1530/EJE-10-0514
48. Courcoulas AP Goodpaster BH Eagleton JK Belle SH Kalarchian MA Lang W Toledo FG Jakicic JM Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial JAMA Surg 2014 149 7 707 715 10.1001/jamasurg.2014.467 24899268
Courcoulas AP, Goodpaster BH, Eagleton JK, Belle SH, Kalarchian MA, Lang W, Toledo FG, Jakicic JM (2014) Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg 149(7):707–71524899268 10.1001/jamasurg.2014.467
49. Buscemi S Buscemi C Corleo D De Pergola G Caldarella R Meli F Randazzo C Milazzo S Barile AM Rosafio G Settipani V Gurrera S Borzì AM Ciaccio M Obesity and circulating levels of vitamin d before and after weight loss induced by a very low-calorie ketogenic diet Nutrients 2021 13 6 1829 10.3390/nu13061829 34071985
Buscemi S, Buscemi C, Corleo D, De Pergola G, Caldarella R, Meli F, Randazzo C, Milazzo S, Barile AM, Rosafio G, Settipani V, Gurrera S, Borzì AM, Ciaccio M (2021) Obesity and circulating levels of vitamin d before and after weight loss induced by a very low-calorie ketogenic diet. Nutrients 13(6):182934071985 10.3390/nu13061829
50. Wiley KD, Gupta M. Vitamin B1 (thiamine) deficiency. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright© 2023, StatPearls Publishing LLC; 2023.
51. Lange J Königsrainer A Malnutrition as a complication of bariatric surgery—a clear and present danger? Visc Med 2019 35 5 305 311 10.1159/000503040 31768394
Lange J, Königsrainer A (2019) Malnutrition as a complication of bariatric surgery—a clear and present danger? Visc Med 35(5):305–31131768394 10.1159/000503040
52. Stroh C Meyer F Manger T Beriberi, a severe complication after metabolic surgery - review of the literature Obes Facts 2014 7 4 246 252 10.1159/000366012 25095897
Stroh C, Meyer F, Manger T (2014) Beriberi, a severe complication after metabolic surgery - review of the literature. Obes Facts 7(4):246–25225095897 10.1159/000366012
53. Martel JL, Kerndt CC, Doshi H, Franklin DS. Vitamin B1 (thiamine). StatPearls. Treasure Island (FL): StatPearls Publishing Copyright© 2023, StatPearls Publishing LLC; 2023.
54. Institute of Medicine Panel on M. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, 10.17226/10026. Washington (DC): National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved; 2001.
55. Alvarez-Leite JI Nutrient deficiencies secondary to bariatric surgery Curr Opin Clin Nutr Metab Care 2004 7 5 569 575 10.1097/00075197-200409000-00010 15295278
Alvarez-Leite JI (2004) Nutrient deficiencies secondary to bariatric surgery. Curr Opin Clin Nutr Metab Care 7(5):569–57515295278 10.1097/00075197-200409000-00010
56. Moizé V Andreu A Flores L Torres F Ibarzabal A Delgado S Lacy A Rodriguez L Vidal J Long-term dietary intake and nutritional deficiencies following sleeve gastrectomy or Roux-En-Y gastric bypass in a mediterranean population J Acad Nutr Diet 2013 113 3 400 410 10.1016/j.jand.2012.11.013 23438491
Moizé V, Andreu A, Flores L, Torres F, Ibarzabal A, Delgado S, Lacy A, Rodriguez L, Vidal J (2013) Long-term dietary intake and nutritional deficiencies following sleeve gastrectomy or Roux-En-Y gastric bypass in a mediterranean population. J Acad Nutr Diet 113(3):400–41023438491 10.1016/j.jand.2012.11.013
57. Smelt HJM Pouwels S Smulders JF Hazebroek EJ Patient adherence to multivitamin supplementation after bariatric surgery: a narrative review J Nutr Sci 2020 9 e46 10.1017/jns.2020.41 33101663
Smelt HJM, Pouwels S, Smulders JF, Hazebroek EJ (2020) Patient adherence to multivitamin supplementation after bariatric surgery: a narrative review. J Nutr Sci 9:e4633101663 10.1017/jns.2020.41
58. Neri B Bigarelli P Filippi F Belligoli A Bettini S Busetto L di Cola RS Giardiello C Paolini B Del Ciondolo I Efficacy evaluation of a medical food supplementation as prevention and therapy of nutritional deficiency in bariatric surgery IJMDAT 2020 3 e235
Neri B, Bigarelli P, Filippi F, Belligoli A, Bettini S, Busetto L, di Cola RS, Giardiello C, Paolini B, Del Ciondolo I (2020) Efficacy evaluation of a medical food supplementation as prevention and therapy of nutritional deficiency in bariatric surgery. IJMDAT 3:e235
